Blood flow restriction therapy after hip surgery
Official title: Postoperative Blood Flow Restriction Training Following Hip Arthroscopy: A Randomized Clinical Trial
Run by Rush University Medical Center · NCT04113759 · Data updated 2026-11-12
This study is testing if a special therapy that restricts blood flow can help people recover stronger and faster after hip surgery for certain injuries.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years to 40 Years |
| Sex | All |
| Enrollment | 56 (estimated) |
| Sponsor | Rush University Medical Center Academic / other |
| Locations | 1 site (Chicago, Illinois) |
| Status | Recruiting |
| Started | August 1, 2023 |
| Main results expected | November 2027 |
| Study ends | January 2028 |
| Registry record updated | December 5, 2025 |
| Trial ID | NCT04113759 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are English-speaking adults aged 18-40 scheduled for primary hip arthroscopy due to labral pathology or femoral acetabular impingement.
✕Probably not a fit
Patients over 40, those with prior hip or knee surgeries, or individuals with certain medical conditions may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This clinical trial evaluates the effectiveness of blood flow restriction (BFR) therapy in enhancing muscle growth and strength recovery in patients undergoing hip arthroscopy for femoral acetabular impingement and labral tears. Participants will be randomly assigned to receive either BFR therapy or a sham treatment, with their progress monitored through strength testing, leg measurements, and MRI assessments over a year. The study aims to determine if BFR can improve rehabilitation outcomes compared to standard recovery methods.
Why it matters
Potential benefit: If successful, this approach could lead to improved muscle recovery and rehabilitation outcomes for patients after hip arthroscopy.
How similar studies have gone: Other studies have shown promising results with blood flow restriction therapy in various rehabilitation settings, suggesting potential for success in this novel application.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Adult patients 18-40 * English-speaking * Clinical and radiographic examination (MRI) consistent FAIS and/or labral pathology, and are schedule for primary hip arthroscopy * Written and informed consent for study participation Exclusion Criteria: * Patients younger than 18 or older than 40 years of age * Non-native English speaker * Revision surgery or prior history of ipsilateral hip or knee surgery * Inability to comply with the proposed follow-up clinic visits * Patients lacking decisional capacity * Patients with a history of deep vein thrombosis, pulmonary embolism, or known clotting disorder or hypercoagulable state * Pregnant or breast-feeding women. Pregnancy as determined by a positive pregnancy test prior to procedure. Females of childbearing potential must agree to use an acceptable birth control method during study participation. * Worker's compensation patients * Any clinically significant finding that would place the patient at health risk, impact the study, or affect the completion of the study * Any psychiatric illness that would prevent comprehension of the details and nature of the study and interfere with follow-up clinic visits
Where it's running
-
Rush University Medical Center
Chicago, Illinois, United States Recruiting
Study contacts
- Principal investigator: Jorge Chahla, MD PhD — Rush University Medical Center
- Study coordinator: Carla M. Edwards, PhD
- Email: carla_edwards@rush.edu
- Phone: 312-563-5735
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Investigating opioid prescriptions after hip arthroscopy
This study is testing if giving fewer pain pills after hip surgery can still help patients manage their pain while using less medication.
-
Pharmacist-led blood pressure care delivered in Chicago neighborhoods
This program tests whether a mobile pharmacist-led team can help adults with uncontrolled high blood pressure on Chicago's West and South Sides lower their blood pressure when care is offered in trusted community settings.
-
Paracervical Block With Ketorolac and Lidocaine for Osmotic Dilator Placement
This study tests whether a ketorolac and lidocaine injection around the cervix improves pain control for people needing osmotic dilators before a second-trimester abortion.
-
PTSD treatment delivered by your primary care nurse
This will test whether nurses trained to deliver a short, four-session trauma therapy can help primary care patients who develop PTSD after a recent life-threatening heart or stroke event.
-
Holmium laser versus electrohydraulic lithotripsy for difficult bile duct and pancreatic duct stones
This will test whether a low-power holmium laser works and is as safe as electrohydraulic lithotripsy for adults with large or hard-to-remove bile duct or pancreatic duct stones.
-
How skin tone affects pulse oximeter oxygen readings
This study will see if pulse oximeters give different oxygen readings in adults with different skin tones by comparing their readings to arterial blood gas measurements.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.